Tag: AVF
EVC 2025: Multidisciplinary, multi-stakeholder efforts key to setting venous disease research...
Addressing the audience at the 28th European Vascular Course (EVC 2025) in Maastricht, The Netherlands (March 9–11), Ulka Sachdev-Ost, MD, from the University of...
Venous VQI celebrates decade milestone
At the recent VEITHsymposium (Nov. 19–23) in New York City, Marc Passman, MD, reflected on the achievements of the Society for Vascular Surgery (SVS)...
VVT Medical receives endorsement letter from AVF on CPT coding guidance...
VVT Medical recently announced that the American Venous Forum (AVF) has provided an official opinion letter regarding CPT coding guidance for the ScleroSafe percutaneous...
Societies seek consensus on NIVL management amid ‘paucity of rigorous data’
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular...
SVS, AVF bring the latest innovations in venous disease treatment to...
During the first day of VAM 2024, the Society for Vascular Surgery (SVS) and American Venous Forum (AVF) have co-sponsored a session on the...
As temporal trends in hemodialysis access creation emerge, notion of AV...
The 2024 Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 24–27) hears three separate talks—two scientific papers and one from an invited guest...
New varicose vein management guidelines released
The SVS, in collaboration with the American Venous Forum (AVF) and the American Vein and Lymphatic Society (AVLS), has unveiled part two of...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by...
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
Vascular Specialist–February 2023
In this issue:
Educate, and educate, and educate again: The continuing quest for appropriate venous care (p. 1 and 6)
Likes, dislikes and reposts:...
The top 10 most popular Vascular Specialist stories in March
Among the posts catching Vascular Specialist readers' eyes last month were the digital flipbook version of our March print edition, a new study looking...
Vascular Specialist–April 2022
In this issue:
In our April cover story, we report from the Society for Clinical Vascular Surgery (SCVS) Annual Symposium on new evidence that...
Select gene SNPs found to be associated with venous ulcer formation...
Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...
AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT)...
AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF)...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
VQI launches fellowship in training program, announces scholarship
The Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) is launching a new SVS Patient Safety Organization VQI Fellowship in Training (SVS PSO...
First-in-human study of Wrapsody endoprosthesis yields ‘very promising’ results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
CMS creates new billing code for central venous vascular access system
Bluegrass Vascular Technologies announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a new Healthcare Common Procedure Coding System (HCPCS)...
Fist Assist device achieves significant perforator vein dilation for improved endoAVF...
Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial (FACT...
VAM: Spotlight on Tuesday and Wednesday
It’s nearly opening day for the Vascular Annual Meeting (VAM) and our schedule is jammed with sessions of interest. Here are presentations to consider...
Artio Medical completes enrollment of first-in-human trial investigating Amplifi vein dilation...
Artio Medical announced today it has completed enrollment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were...
AVFs contribute to higher survival of hemodialysis patients with COVID-19
A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of hemodialysis patients with COVID-19. Authors Ahmet Murt,...
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs)...
Emerging picture: VAM 2021 shaping up into blockbuster event
The moving pieces that comprise the 2021 Vascular Annual Meeting (VAM), set to take place Aug. 18–21 at the San Diego Convention Center, San...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....
Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter
Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...
Venous2021 kicks off Wednesday, March 17
The American Venous Forum (AVF) will hold its 33rd annual meeting, Venous2021, in a virtual format from March 17–20.
The conference features scientific sessions covering...
AVF schedules education series for trainees, early-career practitioners
The American Venous Forum (AVF) is to stage a four-part series of educational sessions running the gamut of venous disorders aimed at residents, fellows...
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
AMELIA ISLAND, Fla.—As a podium talk at the annual meeting of the American Venous Forum (AVF), it represented a bit of an outlier. It...